Highlights
Trinity Capital committed up to USD 50 million in growth funding to Nalu Medical, Inc.
Nalu’s Neurostimulation System is FDA-cleared and designed for minimally invasive treatment of chronic neuropathic pain.
Nalu recently received FDA clearance for expanded labelling of its Peripheral Nerve Stimulation therapy for whole-body MRI-conditional use.
Trinity Capital Inc. (Nasdaq:TRIN), a leading alternative asset manager, announced a commitment of up to USD 50 million in growth funding to Nalu Medical, Inc. (Nalu), a commercial-stage medical device company. The funding will support Nalu’s ongoing development and commercialization of its neurostimulation solutions for patients with chronic intractable neuropathic pain.
Trinity Capital provides capital to growth-oriented companies through multiple financing structures and views the Nalu partnership as aligned with its life sciences focus within its investment portfolio.
Nalu’s Proprietary Neurostimulation System
Nalu Medical is advancing treatment for chronic neuropathic pain through its proprietary implantable pulse generator (IPG) technology. The Nalu Neurostimulation System features a compact, non-integrated, implanted medical device that utilizes advanced electrical impulse waveforms to interrupt pain signals before they reach the brain.
The micro-IPG device is minimally invasive, battery-free, and designed to be operated by patients through a smartphone interface. This approach aims to offer a less intrusive option for patients while maintaining clinical effectiveness in managing chronic pain conditions.
Expanded FDA Clearance
Nalu’s device has already been FDA-cleared for implantation. Recently, the company secured additional FDA clearance for expanded labelling of its Peripheral Nerve Stimulation (PNS) therapy. With this update, the therapy is now approved for whole-body MRI-conditional use, broadening treatment accessibility and compatibility for patients requiring imaging procedures.
About Trinity Capital
Headquartered in the United States, Trinity Capital Inc. (Nasdaq:TRIN) is an international alternative asset manager specializing in private credit markets. The company structures investments in growth-oriented businesses and provides financing across five verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset-Based Lending, and Life Sciences.
About Nalu Medical
Based in Carlsbad, California, Nalu Medical, Inc. develops and commercializes neurostimulation solutions designed to treat chronic neuropathic pain. Its Neurostimulation System delivers electrical pulses to modulate pain pathways, addressing unmet medical needs in the pain management market.
The Nalu System has been developed with a focus on providing minimally invasive treatment options and delivering long-term value to both patients and healthcare providers.